Hi, folks, how are you today? As we mentioned yesterday, we are continuing to grapple with a web site redesign. At some point today, Pharmalot will look different than it has for the past few years and this, of course, also means that we are encountering new tricks - both good and bad - as we work 'under the hood.' Please bear with us as we undergo the transition. Any issues? You can write us at pharmalot@gmail.com. As you might imagine, this calls for a few cups of stimulation. Please joins us, as always. Meanwhile, here are some tidbits. Have a great day and stay in touch...
Pfizer Tuberculosis Drug Is In Short Supply (Reuters)
Shire To Pay $160M For Eye-Drug Maker SARCode (Bloomberg News)
CRO Pays $22.5M To Dr. Reddy's To Settle Lawsuit (Outsourcing Pharma)
India Sets Rates For Essential Medicines Prices (Economic Times)
Phytopharm Gives Up On Parkinson's Drug After Failure (Reuters)
Generic Drugmakers For Reproductive Health Coalition (The Hindu)
EDITOR'S NOTE: Please check this post for additional stories during the day